Quinten Health closes its financing round to advance disease modeling platforms
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
This association between the two esteemed organizations allows Medvarsity to significantly – and positively – impact healthcare education
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
Subscribe To Our Newsletter & Stay Updated